Last updated on March 2019

An Observational Study of Presentation Treatment Patterns and Outcomes in Multiple Myeloma Participants


Brief description of study

The purpose of this study is to describe contemporary, real-world patterns of patient characteristics, clinical disease presentation, therapeutic regimen chosen, and clinical outcomes in participants with newly diagnosed [ND] multiple myeloma (MM) and participants with relapsed/refractory [R/R] MM.

Detailed Study Description

This is a prospective, non-interventional, observational study. This study will look at contemporary, real-world patterns of patient characteristics, clinical disease presentation, therapeutic regimen chosen, and clinical outcomes in participants with MM. Participants will not be asked to change their routine clinical treatment. Participants will have to complete patient reported outcomes (PROs) surveys during on-site routine office visits.

The study will enroll approximately 4200 participants. Participants will be assigned to one of the following cohorts based upon the diagnosis of MM:

  • ND MM within 3 months from initiation of treatment
  • R/R MM who have received 1 to 3 prior lines of therapy

This multi-center trial will be conducted worldwide. The overall time to participate in this study is up to 8 years. Participants will be evaluated and followed-up for a period of at least 5 years, until death, are lost to follow-up, or the end of the study, whichever comes first.

Clinical Study Identifier: NCT02761187

Contact Investigators or Research Sites near you

Start Over

CARTI Cancer Center

Little Rock, AR United States
  Connect »

St Joseph Heritage Healthcare

Santa Rosa, CA United States
  Connect »

Poudre Valley Health System

Fort Collins, CO United States
  Connect »

SCRI Florida Cancer Specialists East

Daytona Beach, FL United States
  Connect »

SCRI Florida Cancer Specialists North

Saint Petersburg, FL United States
  Connect »

Central Maine Medical Center

Lewiston, ME United States
  Connect »

Park Nicollet Institute

Saint Louis Park, MN United States
  Connect »

Central Care Cancer Center

Bolivar, MO United States
  Connect »

Kansas City VA Medical Center

Kansas City, MO United States
  Connect »

Hunterdon Hematology Oncology

Flemington, NJ United States
  Connect »

San Juan Oncology Associates

Farmington, NM United States
  Connect »

Saint Francis Hospital

East Hills, NY United States
  Connect »

Mount Sinai Medical Center

New York, NY United States
  Connect »

Levine Cancer Center

Charlotte, NC United States
  Connect »

University of Cincinnati

Cincinnati, OH United States
  Connect »

Fox Chase Cancer Center

Philadelphia, PA United States
  Connect »

Texas Oncology (Loop) - USOR

Amarillo, TX United States
  Connect »

Texas Oncology (Loop) - USOR

Round Rock, TX United States
  Connect »

Texas Oncology (Loop) - USOR

San Antonio, TX United States
  Connect »

Berkeley Medical Center

Martinsburg, WV United States
  Connect »

St Vincent Hospital

Green Bay, WI United States
  Connect »

UZ Gent

Gent, Belgium
  Connect »

Hopital de Jolimont

Haine-Saint-Paul, Belgium
  Connect »

Oncomedica SA

Monteria, Colombia
  Connect »

Royal Bournemouth Hospital

Bournemouth, United Kingdom
  Connect »

Leicester Royal Infirmary

Leicester, United Kingdom
  Connect »

George Washington University

Washington, WA United States
  Connect »

Indiana University

Indianapolis, IN United States
  Connect »

UZ Leuven

Leuven, Belgium
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.